Smith & Nephew plc (SNN)
| Previous close | 23.88 |
| Open | 24.53 |
| Bid | 24.49 x 1100 |
| Ask | 24.51 x 1300 |
| Day's range | 24.42 - 24.53 |
| 52-week range | 21.53 - 33.09 |
| Volume | |
| Avg. volume | 946,498 |
| Market cap | 10.957B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 40.73 |
| EPS (TTM) | 0.60 |
| Earnings date | N/A |
| Forward dividend & yield | 0.75 (3.14%) |
| Ex-dividend date | 01 Apr 2024 |
| 1y target est | 31.50 |
Simply Wall St.With 83% ownership of the shares, Smith & Nephew plc (LON:SN.) is heavily dominated by institutional owners
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
GlobeNewswireSmith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip
- GlobeNewswire
Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia
Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announced an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT™ in Australia during the recent Australian Orthopedics Association COE Meeting in Sydney. A single-use, sterile navigation system with everything provided in a small carton, NAVBIT SPRINT™ is designed to suit busy surgeons -
